Revolve Biotechnologies is a life science company focused on engineering better biomolecules using novel directed evolution technologies.
Revolve offers custom DNA variant libraries and antibody discovery services. Our technology provides rapid access to comprehensive and expansive user-defined diversity, boosting the success rate of biopharmaceutical and enzyme optimization, protein variant discovery, and mutational mapping. Further applications include antibody/ADC/bispecific engineering, affinity maturation, and epitope mapping. The benefits of our novel patent-pending mutagenesis technology means a rapid delivery time at a highly cost-effective price.
The company’s IP portfolio was developed at and licensed from Johns Hopkins University. In addition to its internal protein pipeline, Revolve is currently offering a service for construction of custom DNA variant libraries with industry-leading performance and delivery time.
Revolve Biotechnologies, Inc. has not received any reviews.
Revolve Biotechnologies, Inc. has not received any endorsements.